Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial

Mel Krajden; Darrel Cook; Amanda Yu; Ron Chow; Qiang Su; Wendy Mei; Shelly McNeil; Deborah Money; Marc Dionne; Joel Palefsky; Karuna Karunakaran; Tobias Kollmann; Gina Ogilvie; Martin Petric; Simon Dobson

doi:10.1016/j.vaccine.2013.09.007

Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial

Mel Krajden, Darrel Cook, Amanda Yu, Ron Chow, Qiang Su, Wendy Mei, Shelly McNeil, Deborah Money, Marc Dionne, Joel Palefsky, Karuna Karunakaran, Tobias Kollmann, Gina Ogilvie, Martin Petric, Simon Dobson

Decision Sciences

Research output: Contribution to journal › Article › peer-review

33 Citations (Scopus)

Original language	English
Pages (from-to)	624-630
Number of pages	7
Journal	Vaccine
Volume	32
Issue number	5
DOIs	https://doi.org/10.1016/j.vaccine.2013.09.007
Publication status	Published - Jan 23 2014

ASJC Scopus Subject Areas

Molecular Medicine
General Immunology and Microbiology
General Veterinary
Public Health, Environmental and Occupational Health
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.vaccine.2013.09.007

Cite this

Krajden, M., Cook, D., Yu, A., Chow, R., Su, Q., Mei, W., McNeil, S., Money, D., Dionne, M., Palefsky, J., Karunakaran, K., Kollmann, T., Ogilvie, G., Petric, M., & Dobson, S. (2014). Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial. Vaccine, 32(5), 624-630. https://doi.org/10.1016/j.vaccine.2013.09.007

Krajden, M, Cook, D, Yu, A, Chow, R, Su, Q, Mei, W, McNeil, S, Money, D, Dionne, M, Palefsky, J, Karunakaran, K, Kollmann, T, Ogilvie, G, Petric, M & Dobson, S 2014, 'Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial', Vaccine, vol. 32, no. 5, pp. 624-630. https://doi.org/10.1016/j.vaccine.2013.09.007

@article{3489255c75d042079f9e92ef7acdc285,

title = "Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial",

author = "Mel Krajden and Darrel Cook and Amanda Yu and Ron Chow and Qiang Su and Wendy Mei and Shelly McNeil and Deborah Money and Marc Dionne and Joel Palefsky and Karuna Karunakaran and Tobias Kollmann and Gina Ogilvie and Martin Petric and Simon Dobson",

note = "Funding Information: This work was supported by grants from the Michael Smith Foundation for Health Research ( PJ-HPV-002078 ) and the Merck Investigator-Initiated Studies Program (IIS # 39229 ). The study sponsors had no role in the study design, collection, analysis and interpretation of data, writing of the report, or in the decision to submit the article for publication. ",

year = "2014",

month = jan,

day = "23",

doi = "10.1016/j.vaccine.2013.09.007",

language = "English",

volume = "32",

pages = "624--630",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "5",

}

TY - JOUR

T1 - Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial

AU - Krajden, Mel

AU - Cook, Darrel

AU - Yu, Amanda

AU - Chow, Ron

AU - Su, Qiang

AU - Mei, Wendy

AU - McNeil, Shelly

AU - Money, Deborah

AU - Dionne, Marc

AU - Palefsky, Joel

AU - Karunakaran, Karuna

AU - Kollmann, Tobias

AU - Ogilvie, Gina

AU - Petric, Martin

AU - Dobson, Simon

N1 - Funding Information: This work was supported by grants from the Michael Smith Foundation for Health Research ( PJ-HPV-002078 ) and the Merck Investigator-Initiated Studies Program (IIS # 39229 ). The study sponsors had no role in the study design, collection, analysis and interpretation of data, writing of the report, or in the decision to submit the article for publication.

PY - 2014/1/23

Y1 - 2014/1/23

UR - http://www.scopus.com/inward/record.url?scp=84891664236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891664236&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2013.09.007

DO - 10.1016/j.vaccine.2013.09.007

M3 - Article

C2 - 24055350

AN - SCOPUS:84891664236

SN - 0264-410X

VL - 32

SP - 624

EP - 630

JO - Vaccine

JF - Vaccine

IS - 5

ER -

Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this